Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cystic Fibrosis | 3 | 2025 | 124 | 0.630 |
Why?
|
| Filamins | 1 | 2019 | 8 | 0.620 |
Why?
|
| Asthma | 4 | 2022 | 471 | 0.590 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2019 | 140 | 0.550 |
Why?
|
| Oximetry | 3 | 2021 | 48 | 0.480 |
Why?
|
| Lung | 1 | 2019 | 964 | 0.430 |
Why?
|
| Mutation | 2 | 2025 | 2629 | 0.370 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2012 | 41 | 0.350 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2020 | 32 | 0.300 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2020 | 60 | 0.290 |
Why?
|
| Infant, Premature | 4 | 2021 | 184 | 0.250 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2017 | 61 | 0.250 |
Why?
|
| Oxygen | 2 | 2021 | 321 | 0.230 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2025 | 79 | 0.230 |
Why?
|
| Neonatal Screening | 1 | 2025 | 102 | 0.220 |
Why?
|
| DNA Glycosylases | 1 | 2004 | 22 | 0.220 |
Why?
|
| Genetic Testing | 1 | 2025 | 140 | 0.220 |
Why?
|
| Respiratory Mucosa | 1 | 2004 | 56 | 0.220 |
Why?
|
| Critical Care | 1 | 2008 | 402 | 0.210 |
Why?
|
| DNA Repair | 1 | 2004 | 250 | 0.190 |
Why?
|
| Oxidative Stress | 1 | 2004 | 304 | 0.190 |
Why?
|
| Epithelial Cells | 1 | 2004 | 401 | 0.180 |
Why?
|
| Rhinitis | 1 | 2022 | 25 | 0.180 |
Why?
|
| Sinusitis | 1 | 2022 | 31 | 0.180 |
Why?
|
| Home Care Services, Hospital-Based | 1 | 2020 | 5 | 0.170 |
Why?
|
| Aortic Valve Prolapse | 1 | 2019 | 1 | 0.160 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2019 | 4 | 0.160 |
Why?
|
| Infant, Newborn | 5 | 2025 | 1375 | 0.160 |
Why?
|
| Heterozygote | 1 | 2019 | 171 | 0.150 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 190 | 0.150 |
Why?
|
| Chest Pain | 1 | 2019 | 84 | 0.150 |
Why?
|
| Pulmonary Emphysema | 1 | 2019 | 108 | 0.150 |
Why?
|
| Dyspnea | 1 | 2019 | 124 | 0.150 |
Why?
|
| Blood Glucose | 1 | 2021 | 487 | 0.140 |
Why?
|
| Heart Defects, Congenital | 1 | 2019 | 104 | 0.140 |
Why?
|
| School Nursing | 1 | 2017 | 27 | 0.130 |
Why?
|
| Cough | 1 | 2019 | 183 | 0.130 |
Why?
|
| Craniofacial Abnormalities | 1 | 2017 | 22 | 0.130 |
Why?
|
| Neuromuscular Diseases | 1 | 2017 | 22 | 0.130 |
Why?
|
| Infant, Premature, Diseases | 1 | 2017 | 47 | 0.130 |
Why?
|
| Down Syndrome | 1 | 2017 | 46 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 984 | 0.130 |
Why?
|
| School Health Services | 1 | 2017 | 80 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 181 | 0.120 |
Why?
|
| Humans | 13 | 2025 | 64279 | 0.110 |
Why?
|
| Infant | 4 | 2021 | 1664 | 0.110 |
Why?
|
| Quality of Life | 2 | 2020 | 1257 | 0.110 |
Why?
|
| Young Adult | 2 | 2021 | 4781 | 0.100 |
Why?
|
| Female | 6 | 2025 | 33382 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 1669 | 0.090 |
Why?
|
| Polysomnography | 2 | 2021 | 58 | 0.080 |
Why?
|
| Child | 4 | 2021 | 4583 | 0.070 |
Why?
|
| Algorithms | 2 | 2025 | 1029 | 0.070 |
Why?
|
| Lung Transplantation | 1 | 2008 | 74 | 0.070 |
Why?
|
| Lung Diseases | 1 | 2008 | 183 | 0.060 |
Why?
|
| Massachusetts | 2 | 2025 | 2096 | 0.060 |
Why?
|
| Respiratory Insufficiency | 1 | 2008 | 154 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2025 | 6742 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 788 | 0.060 |
Why?
|
| Cytoprotection | 1 | 2004 | 18 | 0.060 |
Why?
|
| Male | 5 | 2025 | 30323 | 0.050 |
Why?
|
| Genotype | 1 | 2025 | 668 | 0.050 |
Why?
|
| Cell Survival | 1 | 2004 | 582 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2025 | 1164 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 704 | 0.050 |
Why?
|
| Hematologic Tests | 1 | 2021 | 16 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2021 | 97 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 185 | 0.040 |
Why?
|
| Prediabetic State | 1 | 2021 | 53 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2021 | 90 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 205 | 0.040 |
Why?
|
| Cell Line | 1 | 2004 | 2055 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 151 | 0.040 |
Why?
|
| Apoptosis | 1 | 2004 | 1094 | 0.040 |
Why?
|
| Body Weight | 1 | 2020 | 379 | 0.040 |
Why?
|
| Adolescent | 2 | 2021 | 6305 | 0.040 |
Why?
|
| Glucose | 1 | 2021 | 471 | 0.030 |
Why?
|
| Absenteeism | 1 | 2017 | 39 | 0.030 |
Why?
|
| Home Care Services | 1 | 2018 | 98 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 726 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2017 | 158 | 0.030 |
Why?
|
| Risk Factors | 2 | 2017 | 5342 | 0.030 |
Why?
|
| Nurse's Role | 1 | 2017 | 120 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2017 | 205 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 541 | 0.030 |
Why?
|
| Middle Aged | 2 | 2021 | 17923 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2017 | 490 | 0.030 |
Why?
|
| Pediatrics | 1 | 2017 | 261 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2018 | 507 | 0.030 |
Why?
|
| Parents | 1 | 2018 | 395 | 0.030 |
Why?
|
| Medicaid | 1 | 2017 | 362 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 489 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1561 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2017 | 2019 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 3726 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1118 | 0.020 |
Why?
|
| United States | 1 | 2017 | 7923 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 17133 | 0.010 |
Why?
|